Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125283702 | 12528370 | 2 | F | 20160811 | 20160705 | 20160822 | EXP | US-SA-2016SA092516 | AVENTIS | 62.00 | YR | A | F | Y | 56.51000 | KG | 20160822 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125283702 | 12528370 | 1 | PS | TAXOTERE | DOCETAXEL | 1 | Unknown | U | UNK | 20449 | |||||||||
| 125283702 | 12528370 | 2 | SS | TAMOXIFEN | TAMOXIFEN | 1 | Unknown | Y | UNK | 0 | |||||||||
| 125283702 | 12528370 | 3 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Unknown | U | UNK | 0 | |||||||||
| 125283702 | 12528370 | 4 | SS | PERTUZUMAB | PERTUZUMAB | 1 | Unknown | U | UNK | 0 | |||||||||
| 125283702 | 12528370 | 5 | SS | KADCYLA | ADO-TRASTUZUMAB EMTANSINE | 1 | Unknown | U | UNK | 0 | |||||||||
| 125283702 | 12528370 | 6 | SS | XELODA | CAPECITABINE | 1 | Unknown | Y | UNK | 0 | |||||||||
| 125283702 | 12528370 | 7 | C | TAXOL | PACLITAXEL | 1 | 0 | ||||||||||||
| 125283702 | 12528370 | 8 | C | VITAMIN B COMPLEX | CYANOCOBALAMINDEXPANTHENOLNIACINAMIDEPYRIDOXINE HYDROCHLORIDERIBOFLAVIN 5'-PHOSPHATE SODIUMTHIAMINE HYDROCHLORIDEVITAMIN B COMPLEX | 1 | 0 | ||||||||||||
| 125283702 | 12528370 | 9 | C | EXEMESTANE. | EXEMESTANE | 1 | 0 | ||||||||||||
| 125283702 | 12528370 | 10 | C | CALCIUM PLUS VITAMIN D3 | 2 | 0 | |||||||||||||
| 125283702 | 12528370 | 11 | C | PANTHENOL/RETINOL/THIAMINE HYDROCHLORIDE/ASCORBIC ACID/ERGOCALCIFEROL/FOLIC ACID/RIBOFLAVIN/NICOTINA | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125283702 | 12528370 | 1 | Breast cancer |
| 125283702 | 12528370 | 2 | Breast cancer |
| 125283702 | 12528370 | 3 | Breast cancer |
| 125283702 | 12528370 | 4 | Breast cancer |
| 125283702 | 12528370 | 5 | Breast cancer |
| 125283702 | 12528370 | 6 | Breast cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125283702 | 12528370 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125283702 | 12528370 | Hypoaesthesia oral | |
| 125283702 | 12528370 | Hypokalaemia | |
| 125283702 | 12528370 | Neoplasm malignant | |
| 125283702 | 12528370 | Neuropathy peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125283702 | 12528370 | 2 | 20131210 | 20140520 | 0 | |
| 125283702 | 12528370 | 3 | 20131228 | 0 | ||
| 125283702 | 12528370 | 4 | 20140116 | 0 | ||
| 125283702 | 12528370 | 6 | 201602 | 0 | ||
| 125283702 | 12528370 | 7 | 20120208 | 20120208 | 0 |